Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 May, 2018 03:57 IST
Alembic Pharma gets USFDA's tentative nod for Vilazodone HCl tablets
Source: IRIS | 19 Apr, 2017, 11.14AM
Comments  |  Post Comment

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Vilazodone Hydrochloride Tablets, 10mg, 20mg and 40mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Viibryd Tablets, 10 mg, 20mg and 40mg, of Forest Labs LLC. Vilazodone Hydrochloride Tablets are indicated for the treatment of Major Depressive Disorder (MDD). Alembic is currently in litigation with Forest Labs LLC in District Court of Delaware and has stipulated to stay the case in view of the ongoing settlement discussions.

Vilazodone Hydrochloride Tablets have an estimated market size of USD 340 million for twelve months ending December 2016 according to IMS.

Alembic now has a total of 54 ANDA approvals (47 final approvals and 7 tentative approvals) from the USFDA.

Shares of the company gained Rs 12, or 1.97%, to trade at Rs 621.95. The total volume of shares traded was 7,783 at the BSE (11.05 a.m., Wednesday).



Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Infibeam Incorporation to acquire Dubai based Vavian Int'l - 21-May-2018 15:35
Ind-Ra downgrades Reliance Infra and its NCDs to 'BBB+' - 21-May-2018 15:31
UltraTech to acquire demerged cement division of Century Textiles - 21-May-2018 10:38
Thermax to acquire stake of Babcock & Wilcox in JV - 21-May-2018 10:29
L&T Hydrocarbon wins two contracts for fertilizer plants - 21-May-2018 10:24
Banks credit in personal loans too high compared to degrowth in infra sectors: Assocham - 21-May-2018 10:10
Banks credit in personal loans too high compared to degrowth in infra sectors: Assocham - 21-May-2018 10:10
Glenmark Pharma gets nod for Colesevelam HCl tablets - 21-May-2018 10:00
Ashok Leyland quarterly net surges 40% - 18-May-2018 16:38
Bank of Baroda enters into MoU with CCRL - 18-May-2018 16:31
Strides Shasun turns to loss in Jan-Mar quarter - 18-May-2018 15:32
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer